Dr. Ron’s Research Review –  August 12, 2015

©                                                                                                                 

This week’s research review focuses on zeolite for heavy metal detox.

A study included 11 healthy men that were given zeolite, clinoptilolite (Natural Cellular Defense, 15 drops 2x/day) for seven days (Group 1) and 30 days (Group 2). The control group consumed an equal volume of a placebo solution, prepared as 50 ng/ml magnesium silicate and 1 mg/ml citric acid in purified water.
Participants in both groups had increased concentrations of heavy metals in the urine with the peak excretion at around day 4. No clinically significant alterations in serum electrolyte levels were seen at either seven or 30 days on activated clinoptilolite suspended in water (ACS). (Flowers et al., 2009)

Clinical results are shown in Figure 2.

Fold change in urinary excretion is defined as the level of urinary excretion of metal toxins measured by icP-MS prior to initiating activated clinoptilolite supplementation divided by the level of urinary excretion of metal toxins measured at specified time point intervals.

Dr. Ron


 

Articles

Clinical Evidence Supporting The Use Of An Activated Clinoptilolite Suspension As An Agent To Increase Urinary Excretion Of Toxic Heavy Metals
         (Flowers et al., 2009) Download
Effective treatment of chronic illness resulting from the long-term buildup of heavy metals in the body, such as chelation therapy, presents numerous clinical challenges, including undesirable side effects and unpredictable efficacy. Use of a naturally occurring zeolite, clino- ptilolite, to remove these toxic substances may offer an efficacious and safe alternative to the traditional approaches. This study was designed to evaluate the ability of activated clinoptilolite suspended in water (ACS) to remove heavy metals from the body through urinary excretion without the undesirable removal of physiologically important electrolytes. The protocol utilized two treatment groups, each consisting of eleven healthy men aged 36 to 70 years. Volunteers were given a commercially available version of the study substance for seven days (Group 1) and 30 days (Group 2) and urine samples were collected at specified time points in the study. Changes in urinary concentration of the heavy metals were measured by inductively coupled plasma mass spectrometry and compared to the baseline. Also, serum samples were obtained from five individuals in each group and serum electrolytes were measured prior to and after taking the product. Participants in both groups had increased concentrations of heavy metals in the urine with the peak excretion at around day 4. No clinically significant alterations in serum electrolyte levels were seen at either seven or 30 days on ACS. In conclusion, this study demonstrates that the daily use of an activated clinoptilolite suspension represents a potentially safe and effective way to remove toxic heavy metals from the body through increased urinary excretion without removing clinically detrimental amounts of vital electrolytes.

References

Flowers, James L, Stewart A Lonky, and Erik J Deitsch (2009), ‘Clinical Evidence Supporting The Use Of An Activated Clinoptilolite Suspension As An Agent To Increase Urinary Excretion Of Toxic Heavy Metals’, Nutrition and Dietary Supplements, 1 11-18. PubMedID: